Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality

Dalbavancin is a new antibiotic that is effective against Gram-positive microorganisms, including methicillin-resistant Staphylococci, and offers the possibility of administering intravenous therapy once weekly in an ambulatory setting. We conducted a multicenter observational case-control study, co...

Descripción completa

Detalles Bibliográficos
Autores principales: de Pablo-Miró, Mar, Pujol-Ruiz, Sergi, Iftimie, Simona, Arenas-Miras, María del Mar, López-Montesinos, Inmaculada, Duran-Jordà, Xavier, Anglès, Albert, Grau, Santiago, Horcajada, Juan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614661/
https://www.ncbi.nlm.nih.gov/pubmed/34827234
http://dx.doi.org/10.3390/antibiotics10111296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614661/
https://www.ncbi.nlm.nih.gov/pubmed/34827234
http://dx.doi.org/10.3390/antibiotics10111296

Ejemplares similares